| Amgen Switzerland AG - Aranesp 150 Mikrogramm, Injektionslösung in Fertigspritze |
| 55725 | | 10 | | Aranesp 150 Mikrogramm | | Injektionslösung in Fertigspritze | | B03XA02 | | Darbepoetin Alfa | | 13.09.2002 | | |
|
| Composition |
| darbepoetinum alfa 150 µg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.3 ml corresp., natrium 1.14 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Darbepoetin Alfa | 150µg / 0.3ml |
| | BAG: Active Agent | Dose |
|---|
| Darbepoetin Alfa | 0.15 mg |
| | | | Inactive agents |
|---|
| Disodium Phosphate | | Sodium Chloride | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 069 | syringe(s) | | | A | | Yes | | 070 | 4 syringe(s) | 1259.26 | 1385.95 | A | SL | No |
|
